Purification, characterization and molecular cloning of chymotrypsin inhibitor peptides from the venom of Burmese Daboia russelli siamensis

Chun-teng Guo, Stephen McClean, Chris Shaw, Ping-fan Rao, Ming-yu Ye, AJ Bjourson

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

One novel Kunitz BPTI-like peptide designated as BBPTI-1, with chymotrypsin inhibitory activity was identified from the venom of Burmese Daboia russelli siamensis. It was purified by three steps of chromatography including gel filtration, cation exchange and reversed phase. A partial N-terminal sequence of BBPTI-1, HDRPKFCYLPADPGECLAHMRSF was obtained by automated Edman degradation and a Ki value of 4.77 nM determined. Cloning of BBPTI-1 including the open reading frame and 3â�² untranslated region was achieved from cDNA libraries derived from lyophilized venom using a 3â�² RACE strategy. In addition a cDNA sequence, designated as BBPTI-5, was also obtained. Alignment of cDNA sequences showed that BBPTI-5 exhibited an identical sequence to BBPTI-1 cDNA except for an eight nucleotide deletion in the open reading frame. Gene variations that represented deletions in the BBPTI-5 cDNA resulted in a novel protease inhibitor analog. Amino acid sequence alignment revealed that deduced peptides derived from cloning of their respective precursor cDNAs from libraries showed high similarity and homology with other Kunitz BPTI proteinase inhibitors. BBPTI-1 and BBPTI-5 consist of 60 and 66 amino acid residues respectively, including 6 conserved cysteine residues. As these peptides have been reported to have influence on the processes of coagulation, fibrinolysis and inflammation, their potential application in biomedical contexts warrants further investigation.
LanguageEnglish
Pages126- 132
JournalPeptides
Volume43
DOIs
Publication statusPublished - May 2013

Fingerprint

Cloning
Venoms
Chymotrypsin
Purification
Complementary DNA
Peptides
Gene Library
Untranslated Regions
Amino Acids
Chromatography
Coagulation
Protease Inhibitors
Cysteine
Cations
Ion exchange
Peptide Hydrolases
Nucleotides
Genes
Gels
Degradation

Keywords

  • &lt
  • span style='font-style: italic'&gt
  • Daboia russelli siamensis&lt
  • /span&gt
  • venom
  • chymotrypsin inhibitor
  • purification
  • characterization
  • cloning

Cite this

@article{e29951ee478143a0b5b7c39cb331927d,
title = "Purification, characterization and molecular cloning of chymotrypsin inhibitor peptides from the venom of Burmese Daboia russelli siamensis",
abstract = "One novel Kunitz BPTI-like peptide designated as BBPTI-1, with chymotrypsin inhibitory activity was identified from the venom of Burmese Daboia russelli siamensis. It was purified by three steps of chromatography including gel filtration, cation exchange and reversed phase. A partial N-terminal sequence of BBPTI-1, HDRPKFCYLPADPGECLAHMRSF was obtained by automated Edman degradation and a Ki value of 4.77 nM determined. Cloning of BBPTI-1 including the open reading frame and 3{\^a}�² untranslated region was achieved from cDNA libraries derived from lyophilized venom using a 3{\^a}�² RACE strategy. In addition a cDNA sequence, designated as BBPTI-5, was also obtained. Alignment of cDNA sequences showed that BBPTI-5 exhibited an identical sequence to BBPTI-1 cDNA except for an eight nucleotide deletion in the open reading frame. Gene variations that represented deletions in the BBPTI-5 cDNA resulted in a novel protease inhibitor analog. Amino acid sequence alignment revealed that deduced peptides derived from cloning of their respective precursor cDNAs from libraries showed high similarity and homology with other Kunitz BPTI proteinase inhibitors. BBPTI-1 and BBPTI-5 consist of 60 and 66 amino acid residues respectively, including 6 conserved cysteine residues. As these peptides have been reported to have influence on the processes of coagulation, fibrinolysis and inflammation, their potential application in biomedical contexts warrants further investigation.",
keywords = "&lt, span style='font-style: italic'&gt, Daboia russelli siamensis&lt, /span&gt, venom, chymotrypsin inhibitor, purification, characterization, cloning",
author = "Chun-teng Guo and Stephen McClean and Chris Shaw and Ping-fan Rao and Ming-yu Ye and AJ Bjourson",
year = "2013",
month = "5",
doi = "10.1016/j.peptides.2013.02.009",
language = "English",
volume = "43",
pages = "126-- 132",

}

Purification, characterization and molecular cloning of chymotrypsin inhibitor peptides from the venom of Burmese Daboia russelli siamensis. / Guo, Chun-teng; McClean, Stephen; Shaw, Chris; Rao, Ping-fan; Ye, Ming-yu; Bjourson, AJ.

Vol. 43, 05.2013, p. 126- 132.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Purification, characterization and molecular cloning of chymotrypsin inhibitor peptides from the venom of Burmese Daboia russelli siamensis

AU - Guo, Chun-teng

AU - McClean, Stephen

AU - Shaw, Chris

AU - Rao, Ping-fan

AU - Ye, Ming-yu

AU - Bjourson, AJ

PY - 2013/5

Y1 - 2013/5

N2 - One novel Kunitz BPTI-like peptide designated as BBPTI-1, with chymotrypsin inhibitory activity was identified from the venom of Burmese Daboia russelli siamensis. It was purified by three steps of chromatography including gel filtration, cation exchange and reversed phase. A partial N-terminal sequence of BBPTI-1, HDRPKFCYLPADPGECLAHMRSF was obtained by automated Edman degradation and a Ki value of 4.77 nM determined. Cloning of BBPTI-1 including the open reading frame and 3â�² untranslated region was achieved from cDNA libraries derived from lyophilized venom using a 3â�² RACE strategy. In addition a cDNA sequence, designated as BBPTI-5, was also obtained. Alignment of cDNA sequences showed that BBPTI-5 exhibited an identical sequence to BBPTI-1 cDNA except for an eight nucleotide deletion in the open reading frame. Gene variations that represented deletions in the BBPTI-5 cDNA resulted in a novel protease inhibitor analog. Amino acid sequence alignment revealed that deduced peptides derived from cloning of their respective precursor cDNAs from libraries showed high similarity and homology with other Kunitz BPTI proteinase inhibitors. BBPTI-1 and BBPTI-5 consist of 60 and 66 amino acid residues respectively, including 6 conserved cysteine residues. As these peptides have been reported to have influence on the processes of coagulation, fibrinolysis and inflammation, their potential application in biomedical contexts warrants further investigation.

AB - One novel Kunitz BPTI-like peptide designated as BBPTI-1, with chymotrypsin inhibitory activity was identified from the venom of Burmese Daboia russelli siamensis. It was purified by three steps of chromatography including gel filtration, cation exchange and reversed phase. A partial N-terminal sequence of BBPTI-1, HDRPKFCYLPADPGECLAHMRSF was obtained by automated Edman degradation and a Ki value of 4.77 nM determined. Cloning of BBPTI-1 including the open reading frame and 3â�² untranslated region was achieved from cDNA libraries derived from lyophilized venom using a 3â�² RACE strategy. In addition a cDNA sequence, designated as BBPTI-5, was also obtained. Alignment of cDNA sequences showed that BBPTI-5 exhibited an identical sequence to BBPTI-1 cDNA except for an eight nucleotide deletion in the open reading frame. Gene variations that represented deletions in the BBPTI-5 cDNA resulted in a novel protease inhibitor analog. Amino acid sequence alignment revealed that deduced peptides derived from cloning of their respective precursor cDNAs from libraries showed high similarity and homology with other Kunitz BPTI proteinase inhibitors. BBPTI-1 and BBPTI-5 consist of 60 and 66 amino acid residues respectively, including 6 conserved cysteine residues. As these peptides have been reported to have influence on the processes of coagulation, fibrinolysis and inflammation, their potential application in biomedical contexts warrants further investigation.

KW - &lt

KW - span style='font-style: italic'&gt

KW - Daboia russelli siamensis&lt

KW - /span&gt

KW - venom

KW - chymotrypsin inhibitor

KW - purification

KW - characterization

KW - cloning

U2 - 10.1016/j.peptides.2013.02.009

DO - 10.1016/j.peptides.2013.02.009

M3 - Article

VL - 43

SP - 126

EP - 132

ER -